• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $SEAS

    SeaWorld Entertainment Inc.

    Subscribe to $SEAS
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SeaWorld Entertainment, Inc., together with its subsidiaries, operates as a theme park and entertainment company in the United States. The company operates SeaWorld theme parks in Orlando, Florida; San Antonio, Texas; and San Diego, California, as well as Busch Gardens theme parks in Tampa, Florida, and Williamsburg, Virginia. It also operates water park attractions in Orlando, Florida; San Antonio, Texas; Chula Vista, California; Tampa, Florida; and Williamsburg, Virginia. In addition, the company operates a reservations-only theme park in Orlando, Florida and a seasonal park in Langhorne, Pennsylvania. It operates a portfolio of twelve theme parks under the SeaWorld, Busch Gardens, Aquatica, Discovery Cove, Water Country USA, Adventure Island, and Sesame Place brands. The company was formerly known as SW Holdco, Inc. and changed its name to SeaWorld Entertainment, Inc. in December 2012. SeaWorld Entertainment, Inc. was founded in 1959 and is headquartered in Orlando, Florida.

    IPO Year: 2013

    Exchange: NYSE

    Website: seaworldentertainment.com

    Recent Analyst Ratings for SeaWorld Entertainment Inc.

    DatePrice TargetRatingAnalyst
    12/14/2023$60.00 → $57.00Overweight → Equal-Weight
    Morgan Stanley
    11/1/2023$67.00 → $57.00Neutral
    JP Morgan
    7/24/2023$75.00 → $66.00Buy
    Goldman
    5/31/2023$75.00Buy
    Goldman
    5/25/2023Sector Weight
    KeyBanc Capital Markets
    4/20/2023$70.00Overweight
    Morgan Stanley
    7/13/2022Overweight → Sector Weight
    KeyBanc Capital Markets
    4/26/2022$92.00Buy
    Rosenblatt
    3/4/2022$74.00 → $83.00Buy
    Deutsche Bank
    2/25/2022$70.00Neutral
    JP Morgan
    See more ratings

    SeaWorld Entertainment Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • SeaWorld Entertainment downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded SeaWorld Entertainment from Overweight to Equal-Weight and set a new price target of $57.00 from $60.00 previously

      12/14/23 7:48:37 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • JP Morgan resumed coverage on SeaWorld Entertainment with a new price target

      JP Morgan resumed coverage of SeaWorld Entertainment with a rating of Neutral and set a new price target of $57.00 from $67.00 previously

      11/1/23 6:19:32 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Goldman reiterated coverage on SeaWorld Entertainment with a new price target

      Goldman reiterated coverage of SeaWorld Entertainment with a rating of Buy and set a new price target of $66.00 from $75.00 previously

      7/24/23 10:10:47 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Goldman initiated coverage on SeaWorld Entertainment with a new price target

      Goldman initiated coverage of SeaWorld Entertainment with a rating of Buy and set a new price target of $75.00

      5/31/23 7:36:50 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • KeyBanc Capital Markets initiated coverage on SeaWorld Entertainment

      KeyBanc Capital Markets initiated coverage of SeaWorld Entertainment with a rating of Sector Weight

      5/25/23 7:17:18 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Morgan Stanley initiated coverage on SeaWorld Entertainment with a new price target

      Morgan Stanley initiated coverage of SeaWorld Entertainment with a rating of Overweight and set a new price target of $70.00

      4/20/23 9:04:53 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment downgraded by KeyBanc Capital Markets

      KeyBanc Capital Markets downgraded SeaWorld Entertainment from Overweight to Sector Weight

      7/13/22 7:50:14 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Rosenblatt initiated coverage on SeaWorld Entertainment with a new price target

      Rosenblatt initiated coverage of SeaWorld Entertainment with a rating of Buy and set a new price target of $92.00

      4/26/22 6:25:45 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Deutsche Bank reiterated coverage on SeaWorld Entertainment with a new price target

      Deutsche Bank reiterated coverage of SeaWorld Entertainment with a rating of Buy and set a new price target of $83.00 from $74.00 previously

      3/4/22 8:50:09 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • JP Morgan resumed coverage on SeaWorld Entertainment with a new price target

      JP Morgan resumed coverage of SeaWorld Entertainment with a rating of Neutral and set a new price target of $70.00

      2/25/22 9:24:01 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    SeaWorld Entertainment Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Lipman Nathaniel was granted 1,687 shares (SEC Form 4)

      4 - SeaWorld Entertainment, Inc. (0001564902) (Issuer)

      1/4/24 4:46:38 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 3 filed by new insider Lipman Nathaniel

      3 - SeaWorld Entertainment, Inc. (0001564902) (Issuer)

      1/4/24 4:42:26 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Hill Path Capital Partners Co-Investment S Lp was granted 1,902 shares (SEC Form 4)

      4 - SeaWorld Entertainment, Inc. (0001564902) (Issuer)

      1/3/24 4:51:05 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Hill Path Capital Partners Lp was granted 1,902 shares (SEC Form 4)

      4 - SeaWorld Entertainment, Inc. (0001564902) (Issuer)

      1/3/24 4:49:59 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Chambers James P. was granted 1,168 shares, increasing direct ownership by 3% to 38,693 units (SEC Form 4)

      4 - SeaWorld Entertainment, Inc. (0001564902) (Issuer)

      1/3/24 4:48:09 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Gray William was granted 1,438 shares, increasing direct ownership by 3% to 53,559 units (SEC Form 4)

      4 - SeaWorld Entertainment, Inc. (0001564902) (Issuer)

      1/3/24 4:00:36 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Maruyama Yoshikazu was granted 1,192 shares, increasing direct ownership by 2% to 51,397 units (SEC Form 4)

      4 - SeaWorld Entertainment, Inc. (0001564902) (Issuer)

      1/3/24 4:00:40 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Moloney Thomas E was granted 1,045 shares, increasing direct ownership by 2% to 70,651 units (SEC Form 4)

      4 - SeaWorld Entertainment, Inc. (0001564902) (Issuer)

      1/3/24 4:00:27 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Bension Ronald was granted 828 shares, increasing direct ownership by 2% to 54,709 units (SEC Form 4)

      4 - SeaWorld Entertainment, Inc. (0001564902) (Issuer)

      1/3/24 4:00:23 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Narang Neha Jogani was granted 733 shares, increasing direct ownership by 2% to 32,239 units (SEC Form 4)

      4 - SeaWorld Entertainment, Inc. (0001564902) (Issuer)

      1/3/24 4:00:15 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    SeaWorld Entertainment Inc. SEC Filings

    See more
    • SeaWorld Entertainment Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

      8-K - United Parks & Resorts Inc. (0001564902) (Filer)

      2/13/24 4:16:14 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits (Amendment)

      8-K/A - SeaWorld Entertainment, Inc. (0001564902) (Filer)

      1/29/24 6:30:11 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K - SeaWorld Entertainment, Inc. (0001564902) (Filer)

      1/26/24 4:15:14 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - SeaWorld Entertainment, Inc. (0001564902) (Filer)

      1/8/24 5:11:38 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 10-Q filed by SeaWorld Entertainment Inc.

      10-Q - SeaWorld Entertainment, Inc. (0001564902) (Filer)

      11/9/23 7:30:47 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - SeaWorld Entertainment, Inc. (0001564902) (Filer)

      11/8/23 6:37:33 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - SeaWorld Entertainment, Inc. (0001564902) (Filer)

      8/31/23 4:18:27 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 10-Q filed by SeaWorld Entertainment Inc.

      10-Q - SeaWorld Entertainment, Inc. (0001564902) (Filer)

      8/9/23 7:02:30 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - SeaWorld Entertainment, Inc. (0001564902) (Filer)

      8/8/23 6:34:59 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - SeaWorld Entertainment, Inc. (0001564902) (Filer)

      8/1/23 7:37:15 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    SeaWorld Entertainment Inc. Leadership Updates

    Live Leadership Updates

    See more
    • SeaWorld Launches 60th Anniversary Celebrations and Unveils "There's So Much More to Sea"

      Guests are invited to take advantage of limited time promotions on tickets and passes to join the celebrations, which kick off on March 21 with in-park parties and continue with thrilling new rides, shows and experiences coming this summer DOWNLOAD HIGH-RES IMAGES HERE ORLANDO, Fla., Feb. 5, 2024 /PRNewswire/ -- SeaWorld is turning 60 this year, and to celebrate, the world-class parks are throwing a party and marking the occasion throughout the year with all-new themed rides and attractions, exciting new presentations and shows, and plenty of other exclusive ticket and experience offers, plus limited-edition food and beverage items, merchandise and collectibles that will be announced in the

      2/5/24 8:00:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld to Open Exciting One-Of-A-Kind Marine Life Themed Rides and Experiences for the Whole Family in Every Park in 2024

      Become a 2024 Pass Member and be the first to experience the new attractions before they open to the public; 2024 passes on sale now DOWNLOAD MEDIA ASSETS HERE ORLANDO, Fla., Sept. 28, 2023 /PRNewswire/ -- SeaWorld is thrilled to announce it will open one-of-a-kind marine life themed rides and attractions in every SeaWorld park in Spring 2024.  Guests to the award-winning parks in Orlando, San Antonio, and San Diego can look forward to epic journeys and experiences for the whole family that will leave them breathless, drenched, and utterly mesmerized.  Attractions include "Penguin Trek" at SeaWorld Orlando, an all-new family friendly coaster for guests 42-77 inches in height that will transp

      9/28/23 9:00:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment, Inc. Announces the Retirement of Michelle ("Chelle") Adams

      ORLANDO, Fla., July 3, 2023 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS), a leading theme park and entertainment company, today announced that Chelle Adams, Chief Transformation Officer of SeaWorld Entertainment, Inc., intends to retire from SeaWorld in order to pursue personal opportunities effective August 4th, 2023. Ms. Adams will be available to the company over the coming months to ensure a smooth transition.  Marc Swanson, Chief Executive Officer of SeaWorld Entertainment, Inc. said, "On behalf of the entire Company, we want to thank Chelle for her contributions to the Company and wish her well." Chelle Adams said, "I appreciate the opportunity to have been part of the SeaW

      7/3/23 4:50:00 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment, Inc. Announces Eight Leadership Promotions and Organizational Changes to Accelerate Business Transformation, Performance and Growth

      Newly created role of Chief Transformation Officer to be held by current Chief Financial Officer (CFO) and Treasurer; internal interim CFO and Treasurer namedCo-Chief Parks Operation Officer roles created which include one leader for the Florida parks and one for the non-Florida parksThree new Park Presidents announced for parks in Orlando and San AntonioChief Accounting Officer (CAO) namedORLANDO, Fla., Jan. 27, 2023 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS), a leading theme park and entertainment company, today announced the promotion of eight leaders across the business as part of organizational adjustments designed to position the Company for continued growth and long-term

      1/27/23 8:15:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment, Inc. Appoints Michelle F. Adams as Chief Financial Officer and Treasurer

      ORLANDO, Fla., June 17, 2022 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS), a leading theme park and entertainment company, today announced that Michelle "Chelle" F. Adams will assume the role of Chief Financial Officer (CFO) and Treasurer effective today. Ms. Adams served as the Chief Financial Officer of The Cosmopolitan of Las Vegas where she was responsible for oversight of the company's day-to-day external and internal accounting and reporting functions, driving business transformation and process improvement across the organization, and playing a key role in the successful sale of The Cosmopolitan of Las Vegas last month. Prior to joining The Cosmopolitan of Las Vegas, Adams

      6/17/22 8:00:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment, Inc. Announces CFO Transition

      ORLANDO, Fla., May 11, 2022 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS) ("SeaWorld" or the "Company"), a leading theme park and entertainment company, today announced that after a nine-year tenure with the Company, Elizabeth Castro Gulacsy intends to retire from SeaWorld in order to move on to the next chapter of her career effective on December 31, 2022 or upon the appointment of her successor, if earlier. She will continue to serve in a consulting capacity with the Company for an extended period thereafter to ensure a smooth transition. The Company has retained a nationally recognized recruiting firm to conduct a search for this position.  "On behalf of the management team and

      5/11/22 5:10:00 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment, Inc. Appoints Tom Iven as Chief Operating Officer

      ORLANDO, Fla., June 28, 2021 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS), a leading theme park and entertainment company, today announced the appointment of Tom Iven to the position of Chief Operating Officer ("COO") effective June 28, 2021. SeaWorld's Board of Directors unanimously approved the appointment. "We are excited to have Tom join the SeaWorld team as we continue to drive the business forward and emerge an even stronger company post COVID-19," said Marc Swanson, Chief Executive Officer of SeaWorld Entertainment, Inc.  "Tom brings significant theme park operating experience and a long, successful operating track record. I am confident he will make immediate contributio

      6/28/21 7:30:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment, Inc. Appoints Marc Swanson as CEO and Elizabeth Castro Gulacsy as CFO and Treasurer

      ORLANDO, Fla., May 6, 2021 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS), a leading theme park and entertainment company, today announced the appointment of Marc Swanson to the position of Chief Executive Officer ("CEO") and Elizabeth Castro Gulacsy as Chief Financial Officer ("CFO") and Treasurer. All changes are effective immediately. SeaWorld's Board of Directors (the "Board") unanimously approved the appointments. Mr. Swanson previously served as interim CEO and has been with the Company for over 20 years, having held a number of leadership positions including

      5/6/21 6:30:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    SeaWorld Entertainment Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by SeaWorld Entertainment Inc.

      SC 13G - United Parks & Resorts Inc. (0001564902) (Subject)

      2/13/24 1:09:05 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G/A filed by SeaWorld Entertainment Inc. (Amendment)

      SC 13G/A - SeaWorld Entertainment, Inc. (0001564902) (Subject)

      2/14/23 10:41:02 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13D/A filed by SeaWorld Entertainment Inc. (Amendment)

      SC 13D/A - SeaWorld Entertainment, Inc. (0001564902) (Subject)

      11/14/22 4:02:56 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13D/A filed by SeaWorld Entertainment Inc. (Amendment)

      SC 13D/A - SeaWorld Entertainment, Inc. (0001564902) (Subject)

      5/3/22 4:30:32 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13D/A filed by SeaWorld Entertainment Inc. (Amendment)

      SC 13D/A - SeaWorld Entertainment, Inc. (0001564902) (Subject)

      3/2/22 5:04:19 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G/A filed by SeaWorld Entertainment Inc. (Amendment)

      SC 13G/A - SeaWorld Entertainment, Inc. (0001564902) (Subject)

      2/14/22 4:43:31 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G/A filed by SeaWorld Entertainment Inc. (Amendment)

      SC 13G/A - SeaWorld Entertainment, Inc. (0001564902) (Subject)

      2/14/22 4:32:31 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G filed by SeaWorld Entertainment Inc.

      SC 13G - SeaWorld Entertainment, Inc. (0001564902) (Subject)

      2/11/22 10:47:46 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G/A filed by SeaWorld Entertainment, Inc. (Amendment)

      SC 13G/A - SeaWorld Entertainment, Inc. (0001564902) (Subject)

      9/9/21 4:20:10 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G filed by SeaWorld Entertainment, Inc.

      SC 13G - SeaWorld Entertainment, Inc. (0001564902) (Subject)

      7/9/21 5:15:24 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    SeaWorld Entertainment Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SeaWorld San Antonio Reveals Plans for the ALL-NEW Rescue Jr. Hub, a Kid-Friendly World of Discovery Packed with Interactive Play, Immersive Attractions and a One-Of-A-Kind Water Elements - Opening Spring 2025

      2025 Annual Passes are now available with the best benefits ever, including Aquatica for free, free parking, free guest tickets, in-park discounts and exclusive animal experiences; 2025 Annual Pass Members will also be the first to experience Rescue Jr. DOWNLOAD HIGH-RES IMAGES HERE  SAN ANTONIO, Sept. 30, 2024 /PRNewswire/ -- SeaWorld San Antonio today unveiled its plans for an ALL-NEW friendly world of discovery, the Rescue Jr. hub, set to open Spring 2025. This immersive, hands-on adventure zone will transport young guests into the heart of SeaWorld's animal rescue efforts, where they'll tackle immersive rides, conquer towering climbing structures, splash through vibrant water features a

      9/30/24 9:00:00 AM ET
      $PRKS
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Get Ready for Jaw-Dropping Adventures as SeaWorld's Ultimate Shark Experience Returns for 2024

      SeaWorld's week-long Ultimate Shark Experience celebrates sharks in its parks with once-in-a-lifetime fin-credible opportunities for guests of all ages, all while supporting shark conservation DOWNLOAD HIGH-RES IMAGES HERE ORLANDO, Fla., July 2, 2024 /PRNewswire/ -- SeaWorld is thrilled to unveil the return of its highly anticipated Ultimate Shark Experience ticket, available for purchase starting today. This special ticket provides guests with an exclusive opportunity to fully immerse themselves in a day filled with exciting and educational shark-focused activities. From goin

      7/2/24 8:00:00 AM ET
      $PRKS
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld and Coca-Cola Say Cheers to 60 Years with New Celebration Sundays Featuring Exclusive Merchandise Giveaways for Pass Members and Complimentary Beverage Sampling for All Guests

      Coca-Cola Celebration Sundays at SeaWorld start Sunday, June 16th and continue the third Sunday of each month for the rest of the year ORLANDO, Fla., June 13, 2024 /PRNewswire/ -- Coca-Cola is toasting SeaWorld's 60th anniversary by partnering with the parks to host "Celebration Sundays," featuring free beverage sampling for all guests and exclusive, limited-edition co-branded merchandise giveaways for pass members, while supplies last. The events kick-off on Sunday, June 16 and will continue on the third Sunday of each month through the end of the year. Each month's merchandise giveaway will be a new collectible item that will be announced prior to that month's event. June's giveaway is a 2

      6/13/24 8:00:00 AM ET
      $PRKS
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Unveils 60th Anniversary Celebration Plans for 2024

      60th Anniversary celebrations get underway at SeaWorld's parks this month with not-to-be-missed in-park parties, plus a year-long celebration that includes new rides and attractions, new presentations and shows and special pass promotions DOWNLOAD HIGH-RES IMAGES HERE ORLANDO, Fla., March 11, 2024 /PRNewswire/ -- SeaWorld is turning 60 this year, and the parks have revealed big plans to celebrate all year long. The party officially gets started on March 21st – 60 years to the day that SeaWorld first opened its gates in 1964 – and will be in full swing through the weekend and continue throughout the year. The parks are teasing what's to come as the 60th celebrations get underway, including al

      3/11/24 8:00:00 AM ET
      $PRKS
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEAWORLD ENTERTAINMENT, INC. ANNOUNCES FOURTH QUARTER AND FISCAL 2023 EARNINGS RELEASE DATE AND CONFERENCE CALL INFORMATION

      ORLANDO, Fla., Feb. 8, 2024 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS) announced today that it will release its fourth quarter and fiscal 2023 financial results before the market opens on Wednesday, February 28, 2024. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the internet on Wednesday, February 28, 2024, at 9 a.m. Eastern Time. The release and the conference call can be accessed via the Company's website at www.SeaWorldInvestors.com or www.UnitedParksInvestors.com. For those unable to participate in the live webcast, a replay will be available beginning at approximately 12 p.m. Eastern Time on February 28, 20

      2/8/24 4:30:00 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Launches 60th Anniversary Celebrations and Unveils "There's So Much More to Sea"

      Guests are invited to take advantage of limited time promotions on tickets and passes to join the celebrations, which kick off on March 21 with in-park parties and continue with thrilling new rides, shows and experiences coming this summer DOWNLOAD HIGH-RES IMAGES HERE ORLANDO, Fla., Feb. 5, 2024 /PRNewswire/ -- SeaWorld is turning 60 this year, and to celebrate, the world-class parks are throwing a party and marking the occasion throughout the year with all-new themed rides and attractions, exciting new presentations and shows, and plenty of other exclusive ticket and experience offers, plus limited-edition food and beverage items, merchandise and collectibles that will be announced in the

      2/5/24 8:00:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment, Inc. Changing Its Corporate Name to United Parks & Resorts Inc.

      Company is starting the new year with a new name uniting its world-class, award-winning portfolio of iconic parks and experiences ORLANDO, Fla., Jan. 30, 2024 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS), a leading theme park and entertainment company, today announced it will change its name to United Parks & Resorts Inc., effective Feb. 12, 2024. The new name unites the Company's world-class portfolio of seven brands across 13 parks in the United States and Abu Dhabi. The Company's stock ticker symbol on the New York Stock Exchange will change from SEAS to PRKS, with trading as PRKS to begin Feb. 13, 2024. The name change affects only the name of the parent company – SeaWorld E

      1/30/24 8:00:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Orlando Returns Mother-Daughter Manatee Pair to Florida Waters After More than a Year of Rehabilitation and 17,000+ Hours of Specialized Care

      Largest manatee rescue organization in the world performs an unprecedented dozen lifesaving procedures on a single manatee despite expectedly fatal injuries DOWNLOAD HIGH-RES IMAGES HERE ORLANDO, Fla., Jan. 18, 2024 /PRNewswire/ -- Today, SeaWorld Orlando successfully returned Reckless and Churro, a mother and calf manatee duo, to Broward County in Florida after more than a year of incredible rehabilitation at its Rescue Center. The rehabilitation work included 12 lifesaving procedures and more than 17,000 hours of specialized care. Reckless and Churro were rescued in Florida

      1/18/24 6:31:00 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment, Inc. Announces One New Addition to its Board of Directors

      ORLANDO, Fla., Jan. 8, 2024 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS) ("SeaWorld" or the "Company"), a leading theme park and entertainment company, today announced its Board of Directors (the "Board") has elected Nathaniel J. Lipman to serve as a Director of the Company, effective January 2, 2024. "We are pleased to welcome Nat to the Company's Board," said Scott Ross, Chairman of the SeaWorld Board and Managing Partner of Hill Path Capital. "Nat brings significant experience working with and helping to build tremendous value across many companies in the travel, leisure, hospitality and entertainment sectors. We look forward to the important contributions he will make as we c

      1/8/24 5:30:00 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEAWORLD ENTERTAINMENT, INC. ANNOUNCES THIRD QUARTER EARNINGS RELEASE DATE AND CONFERENCE CALL INFORMATION

      ORLANDO, Fla., Oct. 11, 2023 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS) announced today that it will release its third quarter financial results before the market opens on Wednesday, November 8, 2023. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the internet on Wednesday, November 8, 2023, at 9 a.m. Eastern Time. The release and the conference call can be accessed via the Company's website at www.SeaWorldInvestors.com. For those unable to participate in the live webcast, a replay will be available beginning at approximately 12 p.m. Eastern Time on November 8, 2023, under the "Events & Presentations" tab of www.S

      10/11/23 6:30:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    SeaWorld Entertainment Inc. Financials

    Live finance-specific insights

    See more
    • SEAWORLD ENTERTAINMENT, INC. ANNOUNCES FOURTH QUARTER AND FISCAL 2023 EARNINGS RELEASE DATE AND CONFERENCE CALL INFORMATION

      ORLANDO, Fla., Feb. 8, 2024 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS) announced today that it will release its fourth quarter and fiscal 2023 financial results before the market opens on Wednesday, February 28, 2024. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the internet on Wednesday, February 28, 2024, at 9 a.m. Eastern Time. The release and the conference call can be accessed via the Company's website at www.SeaWorldInvestors.com or www.UnitedParksInvestors.com. For those unable to participate in the live webcast, a replay will be available beginning at approximately 12 p.m. Eastern Time on February 28, 20

      2/8/24 4:30:00 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEAWORLD ENTERTAINMENT, INC. ANNOUNCES THIRD QUARTER EARNINGS RELEASE DATE AND CONFERENCE CALL INFORMATION

      ORLANDO, Fla., Oct. 11, 2023 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS) announced today that it will release its third quarter financial results before the market opens on Wednesday, November 8, 2023. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the internet on Wednesday, November 8, 2023, at 9 a.m. Eastern Time. The release and the conference call can be accessed via the Company's website at www.SeaWorldInvestors.com. For those unable to participate in the live webcast, a replay will be available beginning at approximately 12 p.m. Eastern Time on November 8, 2023, under the "Events & Presentations" tab of www.S

      10/11/23 6:30:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment, Inc. Reports Second Quarter and First Six Months 2023 Results

      ORLANDO, Fla., Aug. 8, 2023 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS), a leading theme park and entertainment company, today reported its financial results for the second quarter and first six months of fiscal year 2023. Second Quarter 2023 Highlights Attendance was 6.1 million guests, a decrease of approximately 0.1 million guests from the second quarter of 2022.Total revenue was $496.0 million, a decrease of $8.8 million or 1.7% from the second quarter of 2022.Net income was $87.1 million, a decrease of $29.6 million or 25.3% from the second quarter of 2022.Adjusted EBITDA[1] was $224.2 million, a decrease of $10.2 million or 4.4% from the second quarter of 2022.Total revenu

      8/8/23 6:30:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEAWORLD ENTERTAINMENT, INC. ANNOUNCES SECOND QUARTER EARNINGS RELEASE DATE AND CONFERENCE CALL INFORMATION

      ORLANDO, Fla., July 17, 2023 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS) announced today that it will release its second quarter financial results before the market opens on Tuesday, August 8, 2023. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the internet on Tuesday, August 8, 2023, at 9 a.m. Eastern Time. The release and the conference call can be accessed via the Company's website at www.SeaWorldInvestors.com. For those unable to participate in the live webcast, a replay will be available beginning at approximately 12 p.m. Eastern Time on August 8, 2023, under the "Events & Presentations" tab of www.SeaWorldIn

      7/17/23 6:30:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment, Inc. Reports First Quarter 2023 Results

      ORLANDO, Fla., May 9, 2023 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS), a leading theme park and entertainment company, today reported its financial results for the first quarter of 2023. First Quarter 2023 Highlights Attendance was 3.4 million guests, a decrease of approximately 25,000 guests from the first quarter of 2022.Total revenue was a record $293.3 million, an increase of $22.7 million or 8.4% from the first quarter of 2022.Net loss was $16.5 million, the second smallest net loss in the first quarter and an increase of $7.5 million from the first quarter of 2022.Adjusted EBITDA[1] was a record $72.4 million, an increase of $6.5 million or 9.8% from the first quarter of

      5/9/23 6:30:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEAWORLD ENTERTAINMENT, INC. ANNOUNCES FIRST QUARTER EARNINGS RELEASE DATE AND CONFERENCE CALL INFORMATION

      ORLANDO, Fla., April 19, 2023 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS) announced today that it will release its first quarter financial results before the market opens on Tuesday, May 9, 2023. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the internet on Tuesday, May 9, 2023, at 9 a.m. Eastern Time. The release and the conference call can be accessed via the Company's website at www.SeaWorldInvestors.com. For those unable to participate in the live webcast, a replay will be available beginning at approximately 12 p.m. Eastern Time on May 9, 2023, under the "Events & Presentations" tab of www.SeaWorldInvestors.c

      4/19/23 8:30:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment, Inc. Reports Fourth Quarter and Fiscal 2022 Results

      ORLANDO, Fla., Feb. 28, 2023 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS), a leading theme park and entertainment company, today reported its financial results for the fourth quarter and fiscal year 2022.[1] Fourth Quarter 2022 Highlights Attendance was 4.9 million guests, a decrease of approximately 16,000 guests from the fourth quarter of 2021. Compared to the fourth quarter of 2019, attendance increased by approximately 238,000 guests or 5.1%.Total revenue was a record $390.5 million, an increase of $19.7 million or 5.3% from the fourth quarter of 2021. Compared to the fourth quarter of 2019, total revenue increased by $92.5 million or 31.0%.Net income was $49.0 million, the s

      2/28/23 6:30:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEAWORLD ENTERTAINMENT, INC. ANNOUNCES FOURTH QUARTER AND FISCAL 2022 EARNINGS RELEASE DATE AND CONFERENCE CALL INFORMATION

      ORLANDO, Fla., Feb. 2, 2023 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS) announced today that it will release its fourth quarter and fiscal 2022 financial results before the market opens on Tuesday, February 28, 2023. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the internet on Tuesday, February 28, 2023, at 9 a.m. Eastern Time. The release and the conference call can be accessed via the Company's website at www.SeaWorldInvestors.com. For those unable to participate in the live webcast, a replay will be available beginning at approximately 12 p.m. Eastern Time on February 28, 2023, under the "Events & Presentation

      2/2/23 8:30:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment, Inc. Reports Third Quarter and First Nine Months 2022 Results

      ORLANDO, Fla., Nov. 9, 2022 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS), a leading theme park and entertainment company, today reported its financial results for the third quarter and first nine months of fiscal year 2022[1]. Third Quarter 2022 Highlights Attendance was 7.3 million guests, an increase of 0.1 million guests or 1.5% from the third quarter of 2021. Compared to the third quarter of 2019, attendance decreased by 0.8 million guests or 9.7%. Excluding international guest visitation, group-related attendance, adverse weather impact (including Hurricane Ian), and calendar shift, attendance increased by approximately 2% when compared to the third quarter of 2019.Total rev

      11/9/22 6:30:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEAWORLD ENTERTAINMENT, INC. ANNOUNCES THIRD QUARTER EARNINGS RELEASE DATE AND CONFERENCE CALL INFORMATION

      ORLANDO, Fla., Oct. 13, 2022 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS) announced today that it will release its third quarter financial results before the market opens on Wednesday, November 9, 2022. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the internet on Wednesday, November 9, 2022 at 9 a.m. Eastern Time. The release and the conference call can be accessed via the Company's website at www.SeaWorldInvestors.com. For those unable to participate in the live webcast, a replay will be available beginning at approximately 12 p.m. Eastern Time on November 9, 2022 under the "Events & Presentations" tab of www.Sea

      10/13/22 8:30:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care